DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

AVANIR PHARMACEUTICALS (NASDAQ: AVNR)



company name or ticker

Concert Pharmaceuticals' Shares Slip Despite Favorable FDA Meeting - Analyst Blog

3 Biotech Stocks with Catalysts Incoming: Spectrum, Orexigen, and Avanir

For companies involved in the development of drugs, a PDUFA decision will meaningfully impact their stocks. With this in mind, there are several PDUFA decisions in upcoming months to watch for.

3 Health Care Stocks Under $10 to Trade for Breakouts

AVANIR Pharma Offers Three Presentations for AVP-825 for Acute Treatment of Migraine

Avanir Gains - AVP-825 Hits Phase III Primary Endpoint - Analyst Blog

Morning Market Movers

Benzinga's Top #PreMarket Gainers

Ignyta (RXDX) Jumps: Stock Adds 12.7% in Session - Tale of the Tape

Patients Enrolled in Avanir Study - Analyst Blog

Pipeline Update from Avanir - Analyst Blog

See More Articles...